Braunamide 10mg Capsule: High-Efficacy Immunomodulatory Therapy for Multiple Myeloma and Hematological Malignancies
Product Overview
Braunamide 10mg Capsule is an advanced oncology formulation containing Lenalidomide (10mg).
| Product Attribute | Details |
| Brand Name | Braunamide 10mg Capsule |
| Active Ingredient | Lenalidomide (10mg) |
| Therapeutic Class | Antineoplastics / Immunomodulatory Derivative (IMiD) |
| Manufacturer | Samarth Life Sciences Pvt. Ltd. |
| Commercial Form | Capsules (Oral Administration) |
| Prescription Medicine | YES |
🔬 Mechanism of Action (How It Works)
Lenalidomide, the active molecule in Braunamide 10mg, acts through a multi-pathway mechanism classified under Thalidomide & Its Immunomodulatory Derivatives (IMiDs). It delivers a comprehensive approach to targeting hematologic malignancies:
Immune System Modulation: It alters cellular immunity by stimulating T-cells and Natural Killer (NK) cells, significantly enhancing the body's native capacity to hunt down and eliminate abnormal cancer cells.
Direct Antineoplastic Action: It binds directly to core cellular pathways to induce cell cycle arrest and apoptosis (programmed cell death) within malignant populations.
Anti-Angiogenesis: It blocks the secretion of angiogenic factors (the biological plumbing signals cancer uses to grow new blood vessels), starving tumors of the nutrient supply needed to expand.
Bone Marrow Support: It alters microenvironmental signals in bone marrow to disrupt growth triggers for abnormal plasma lines while encouraging healthy blood cell production.
📋 Approved Therapeutic Indications
International procurement groups look to buy
Multiple Myeloma: Administered frequently as part of combination regimens for adult patients with newly diagnosed or relapsing bone marrow plasma cell cancers.
Myelysplastic Syndromes (MDS): Indicated specifically for transfusion-dependent anemia associated with low- or intermediate-1-risk myelodysplastic syndromes carrying the deletion 5q chromosomal abnormality.
Mantle Cell Lymphoma (MCL): Prescribed for aggressive or resistant cases of non-Hodgkin’s lymphoma, particularly in patients whose disease has progressed following initial standard treatments.
Follicular Lymphoma: Utilized in combination protocols to manage relapsed or refractory follicular lines.
⚠️ Possible Side Effects
While Braunamide 10mg is highly therapeutic, patients should be closely monitored by a clinical specialist for potential adverse events:
Hematologic Effects: Thrombocytopenia (low blood platelet count), Neutropenia (low white blood cells), and Anemia.
Gastrointestinal Distress: Constipation, diarrhea, nausea, or abdominal pain.
Systemic Manifestations: Fatigue, general muscle weakness, localized muscle cramps, and headaches.
Respiratory Concerns: Upper respiratory tract infections or occasional shortness of breath (dyspnea).
Vascular Warning: Increased risk of deep vein thrombosis (DVT) or pulmonary embolism under specific combination treatments.
📦 Essential Documentation Supplied
As a trusted global
Certificate of Analysis (COA) matching exact batch numbers
GMP (Good Manufacturing Practices) Compliance Certificates
Commercial Invoice, Packing List, and Cold-Chain Logistics logs
Material Safety Data Sheet (MSDS)
🌡️ Storage & Handling Instructions
Temperature Control: Store the capsules at stable room temperatures below 30°C (86°F).
Environment: Protect completely from moisture, excessive humidity, and direct sunlight exposure.
Keep in the original tamper-evident blister packaging until administration. Safety: Keep entirely out of reach of children and domestic pets. Capsules should never be opened, crushed, or chewed.
🛑 Disclaimer
PRESCRIPTION MEDICINE IS: YES
Disclaimer: The information provided herein is solely for educational, industrial, and global B2B reference purposes. It does not replace professional medical advice, diagnosis, or treatment. Braunamide 10mg Capsules must be administered strictly under the supervision of a licensed oncologist.
📞 Wholesale Sourcing & Commercial Contact Details
[GROUP OF PRIME CARE IMPEX PVT. LTD.]
Your Trusted Pharmaceutical Exporter, Bulk Supplier, and Global Distributor from India.
🌐 Corporate Website:
www.medicineexporterfromindia.com 📧 Commercial Email:
exports@ernestpharmaceuticals.com 📦 Business Capabilities: Wholesale Exporting | Institutional Bulk Supply | Global Trade Logistics
📲 Direct WhatsApp Line:
+91 9673008130 🔗 Instant Chat Access:
https://wa.me/919673008130
